Inventor
Ward M. Peterson
Inventor
Morrisville, NC, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07HSugars20%
C07DHeterocyclic compounds7%
A61FFilters implantable into blood vessels6%
C10MLubricating compositions2%
C10NIndexing scheme associated with subclass c10m relating to lubricating compositions2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
8,604,205'Cytoskeletal active rho kinase inhibitor compounds, composition and use'20138,604,218'Cytoskeletal active rho kinase inhibitor compounds, composition and use'20138,410,147'Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds'20138,299,096'Method for treating pulmonary diseases using rho kinase inhibitor compounds'20128,207,195'Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds'20128,071,779'Cytoskeletal active rho kinase inhibitor compounds, composition and use'20118,008,274'P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis'20117,612,047'Degradation-resistant mononucleoside phosphate compounds'20097,531,525'P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating cystic fibrosis'20097,435,724'Degradation-resistant mononucleoside phosphate compounds'20087,256,183'Method for treating or preventing inflammatory diseases'20077,223,744'Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof'20077,115,585'Compositions for treating epithelial and retinal tissue diseases'20067,084,128'Method for reducing intraocular pressure'20067,078,391'Method of treating edematous retinal disorders'20066,881,725'Method for treating pain'20056,864,243'Method for treating retinal degeneration with purinergic receptor agonists'20056,818,629'Pharmaceutical formulation comprising P1-(2\'-deoxycytidine 5\'-)P4-(uridine 5\'-) tetraphosphate'20046,730,707'Method for reducing intraocular pressure using indole derivatives'20046,624,150'Method of treating gastrointestinal tract disease with purinergic receptor agonists'20036,596,725'Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2013Patents assigned to INSPIRE PHARMACEUTICALS INC (20)· patent assignee history
2003–2005Based in Durham, NC, US· patent location history
2004–2013Based in Morrisville, NC, US· patent location history
2011–2013Patents assigned to LAMPE JOHN W (6)· patent assignee history
2011–2013Patents assigned to PETERSON WARD M (6)· patent assignee history
2011–2013Patents assigned to CREAN CHRISTOPHER S (3)· patent assignee history
2011–2013Patents assigned to DECAMP JONATHAN BRYAN (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INSPIRE PHARMACEUTICALS INC | 20 | 2003–2013 |
| LAMPE JOHN W | 6 | 2011–2013 |
| PETERSON WARD Mself | 6 | 2011–2013 |
| CREAN CHRISTOPHER S | 3 | 2011–2013 |
| DECAMP JONATHAN BRYAN | 3 | 2011–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Morrisville, NC, US | 17 | 2004–2013 |
| Durham, NC, US | 4 | 2003–2005 |